| 9428439 |
Hydrobenzamide derivatives as inhibitors of Hsp90 |
Martyn Frederickson, John Francis Lyons, Neil Thomas Thompson, Mladen Vinkovic, Andrew James Woodhead +1 more |
2016-08-30 |
|
| 8796244 |
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases |
Valerio Berdini, Maria Grazia Carr, Miles Stuart Congreve, Martyn Frederickson, Charlotte Mary Griffiths-Jones +11 more |
2014-08-05 |
|
| 8664218 |
Pharmaceutical compounds |
Martyn Frederickson |
2014-03-04 |
|
| 8653084 |
Hydrobenzamide derivatives as inhibitors of Hsp90 |
Martyn Frederickson, Mladen Vinkovic, Andrew James Woodhead, Alison Jo-Anne Woolford |
2014-02-18 |
|
| 8383619 |
Pharmaceutical compounds |
Martyn Frederickson |
2013-02-26 |
|
| 7598386 |
Sulphones which modulate the action of gamma-secretase |
Jose Luis Castro Pineiro, Ian Churcher, Kevin Dinnell, Timothy Harrison, Sonia Kerrad +6 more |
2009-10-06 |
$46,778,000 |
| 7595344 |
Sulphones which modulate the action of gamma secretase |
Jose Luis Castro Pineiro, Ian Churcher, Kevin Dinnell, Timothy Harrison, Sonia Kerrad +6 more |
2009-09-29 |
$72,553,000 |
| 7410964 |
Cyclohexyl sulphones as gamma-secretase inhibitors |
Kevin Dinnell, Karl Richard Gibson, Timothy Harrison, Richard Alexander Jelley, Alan John Nadin +3 more |
2008-08-12 |
$60,980,000 |
| 7342009 |
Cyclic sulfonamides for inhibition of gamma-secretase |
Kevin Dinnell, Timothy Harrison, Alan John Nadin, Andrew Pate Owens, Duncan Shaw |
2008-03-11 |
$221,799,000 |
| 7304094 |
Cyclohexyl sulphones |
Ian Churcher, Kevin Dinnell, Timothy Harrison, Sonia Kerrad, Alan John Nadin +4 more |
2007-12-04 |
$114,023,000 |
| 7265110 |
Tetrahydropyran derivatives and their use as therapeutic agents |
Jose Luis Castro Pineiro, Duncan Shaw |
2007-09-04 |
$99,865,000 |
| 7138400 |
Sulfamides as gamma-secretase inhibitors |
Ian Collins, Joanne Claire Hannam, Timothy Harrison, Stephen Lewis, Andrew Madin +1 more |
2006-11-21 |
$113,439,000 |
| 6984663 |
Cyclohexyl sulphones |
Ian Churcher, Kevin Dinnell, Timothy Harrison, Sonia Kerrad, Alan John Nadin +4 more |
2006-01-10 |
$155,445,000 |
| 6964981 |
Tetrahydrofuran derivatives and their use as NK-1 antagonists |
Christopher John Swain, Simon Owen |
2005-11-15 |
$128,009,000 |
| 6638930 |
Morpholine and thiomorpholine tachykinin receptor antagonists |
Conrad P. Dorn, Paul E. Finke, Jeffrey J. Hale, Malcolm MacCoss, Sander G. Mills +4 more |
2003-10-28 |
$42,446,000 |
| 6613765 |
Use of NK-1 receptor antagonists for treating major depressive disorders |
Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more |
2003-09-02 |
$134,242,000 |
| 6489343 |
Tetrahydropyran derivatives and their use as therapeutic agents |
Jose Luis Castro Pineiro, Simon Owen, Eileen Mary Seward, Christopher John Swain |
2002-12-03 |
$100,921,000 |
| 6458830 |
Tetrahydropyran derivatives and their use as therapeutic agents |
Simon Owen, Eileen Mary Seward, Christopher John Swain |
2002-10-01 |
$109,573,000 |
| 6271230 |
Use of NK-1 receptor antagonists for treating cognitive disorders |
Raymond Baker, Jason Matthew Elliott, Neil Roy Curtis, Timothy Harrison, Gregory John Hollingworth +5 more |
2001-08-07 |
$173,294,000 |
| 6235735 |
Morpholine and thiomorpholine tachykinin receptor antagonists |
Conrad P. Dorn, Jeffrey J. Hale, Paul E. Finke, Malcolm MacCoss, Sander G. Mills +4 more |
2001-05-22 |
$314,770,000 |
| 6172077 |
Spiro-azacyclic derivatives and their use as therapeutic agents |
Neil Roy Curtis, Jason Matthew Elliott, Gregory John Hollingworth, Philip Stephen Jackson, Janusz Jozef Kulagowski +2 more |
2001-01-09 |
$213,886,000 |
| 6114315 |
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety |
Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more |
2000-09-05 |
$380,270,000 |
| 6100256 |
Use of NK-1 receptors antagonists for treating schizophrenic disorders |
Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more |
2000-08-08 |
$326,701,000 |
| 6096729 |
Use of NK-1 receptor antagonists for treating amnestic disorders |
Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more |
2000-08-01 |
$169,201,000 |
| 6087348 |
Use of NK-1 receptor antagonists for treating stress disorders |
Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more |
2000-07-11 |
$231,145,000 |
